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Network connectivity is shown to change in C57BL/6 mice during a
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ABSTRACT
We have already demonstrated (Stojanovic et al., 2009) a connection between tetanus toxoid (TTd) hyperimmunization and the
induction of anti-phospholipid syndrome (APS) in BALB/c mice. Here we show that C57BL/6 mice subjected to an identical procedure
do not exhibit any like pathology attributable to anti-phospholipid antibodies; we explain that this absence results from idiotypic
connectivity. Six groups of C57BL/6 mice were hyperimmunized with TTd in aluminum hydroxide or glycerol, with or without
pretreatments. Pretreated mice had been injected with polyclonal or nonspecific immune stimulators, such as complete Freund’s
adjuvant (CFA) or glycerol. The epitope specificity of induced antibodies was tested by indirect ELISA using a tetanus toxoid
immunogen and these autoantigens: phospholipids, gangliosides, laminin. Idiotypic connectivity was tested by competitive ELISA and
gauged from the degree to which the interaction of idiotypic/anti-idiotypic complementary antibodies was inhibited in the presence of
immunized sera antibodies. Higher idiotypic connectivity was noted amongst pretreated mice. There was a positive correlation
between higher connectivity and autoantibody levels that acted to favor the participation of natural autoantibodies in the inhibitory
process. We conclude that idiotypic connectivity plays a protective role in immunization-induced autoimmunity.
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INTRODUCTION
Of the mechanisms that may contribute to autoantibody
(AAb) generation, those most often cited are molecular
mimicry (Croxford et al., 2005, Samarkos & Vaiopoulos,
2005) and polyclonal cell activation (Wickham &Carr, 2004,
Ramos et al., 2005). Antibodies (Abs) generated during
immunization, whether immunogen- or self-specific, may
have either public or private idiotypes (Ids) (Reilly & Root,
1986, Hebert et al., 1990). These two Ids generate anti-
idiotype (anti-Id) Abs, respectively regarded as either
autoantigens or AAbs; a network of interacting Ids and anti-
Id Abs is thereby formed in consequence (Jerne, 1974, 2004 b,
Vani et al., 2009). It is not suggested that the network
potentially created by Id/anti-Id interactions following
immunization is regulatory in nature; this is at variance with
the network of Id/anti-Id interactions between natural
autoantibodies (NAAbs) with public Id (Vani et al., 2008,
Varela & Coutinho, 1991, Coutinho, 1995). Since anti-Ids may
be thought of as virtual AAbs, it is valid in this context to
invoke the mechanisms of AAb induction when analyzing
changes (be they qualitative or quantitative) in connectivity
between Ids and anti-Ids induced during immunization,
these mechanisms being selective polyclonal B cell expansion
(Sutmuller et al., 1999) and/or an antigen-driven process
(Shoenfeld, 1994, Atassi & Casali,  2008) followed by
mutations and strong Abs selection. Altered connectivity
between Ids and anti-Ids may perhaps be the primum movens
of autoimmune diseases; the loss of Id connectivity in the
course of autoimmune diseases has been variously reported
(Rossi et al., 1990, Very et al., 1993, Dwyer et al., 1986,
Pacheco-Garcia et al . ,  1999, Poletaev, 2002).  The
demonstratedly beneficial therapeutic effect of intravenous
immunoglobulin (IVIG) administered to patients suffering
from autoimmune disease, though its mode of operation is
yet to be fully elucidated, lends credence to its importance in
the restoration of Id connectivity (Dalakas, 2004, Kazatchkine
& Kaveri, 2001, Bayary et al., 2006).
In this paper we analyze changes in natural Id expression
and AAb connectivity in the sera of C57BL/6 mice
hyperimmunized with tetanus toxoid (TTd) in conformity
with six immunization protocols. TTd was the immunogen of
choice because it is a partial structural homolog of beta2-
glycoprotein I (β2GPI), a major autoantigen in
antiphospholipid syndrome (APS)(Blank et al.,  2002);
furthermore, we have already demonstrated a link between
TTd hyperimmunization and APS induction in BALB/c mice,
when the severity of the pathology (fetal resorptions) was
shown to be TTd administration context dependent
(Stojanovic et al., 2009). The pathological response found in
TTd-hyperimmunized BALB/c mice is in stark contrast to the
case of C57BL/6 mice where this type of reproductive
pathology has not been observed. It is hypothesized that the
absence (whatever the context of TTd administration) of this
characteristic reproductive pathology subsequent to
immunization in the C57BL/6 strain may be explained by a
synchronized elevation of highly connected AAbs, which curb
the effects of any pathological antibodies that may be present.
These were our hyperimmunization protocols:  a
hyperdose of TTd in either aluminum hydroxide or glycerol
adjuvants was injected into non-, glycerol or CFA-pretreated
C57BL/6 mice; we thus generated six groups of dissimilarly
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immunized animals from the six possible permutations of
adjuvant and pretreatment.
Antibody profiles were studied over a period of 22 weeks
with nine blood sera samples being taken at two-week
intervals: preliminary samples of untreated sera were taken
immediately before pretreatments, one week before the
beginning of the course of immunizations; eight further
samples of treated blood sera were taken every two weeks
thereafter; a tenth and final sample was taken one week after
the administration of the TTd booster dose. We were
monitoring for changes in: Id/anti-Id connectivity; reactivity
towards immunogen (TTd) and autoantigens (β2GPI,
phospholipids,  gangliosides and laminin);  isotype
composition.
The expression of natural Ids on TTd-immunized mouse
Abs during the course of immunization was tracked via the
inhibition of interaction in a complementary idiotypic pair:
idiotype IgM DJ and its specific anti-idiotypic murine
monoclonal antibody (MoAb) Y7.
The Y7 idiotope was first described occurring on human
IgM molecules (IgM DJ) and then classified as natural.
Natural, firstly, from its expression, detected on 5 % to 8 %
of IgM from cord blood sera (Radulovic et al., 1997) and from
the sera of patients suffering chronic lymphocytic leukemia
(Ivanovic et al., 1990). Natural, secondly, from its IgM DJ
properties, binding to ssDNA, lactic acid bacteria (LAB) and
phosphorylcholine (PC) passively adsorbed to bovine serum
albumin (BSA) (Dimitrijevic et al., 1999). The Y7 idiotope
was assigned to the subgroup VH3 (Dimitrijevic et al., 2004
a).
The anti-idiotypic property of MoAb Y7 was characterized
by its ability to inhibit IgM DJ immunogen binding to PC
adsorbed to BSA (Dimitrijevic et al., 1992). This ability,
indicative of internal image properties, leads to its typing as
an analog of Ab2-beta. It may be regarded as an internal
image of the natural idiotype. That the Y7 idiotype/MoAb Y7
pair has a regulatory function in a murine immune system
was shown from its property of shaping the immune response
against LAB in BALB/c mice (Dimitrijevic et al., 2004 b).
Our results show that the pretreatments shaped the
profiles of analyzed AAbs, tending to the hypothesis that
polyclonal-induced antibody Id interactions participated in
both the pathology and in the control of the immune
response. The absence in the C57BL/6 strain of the
characteristic reproductive pathology (fetal resorption)
found earlier in BALB/c mice consequent to immunization
(Stojanovic et al., 2009) may be explained by a synchronized
elevation of these highly-connected AAbs neutralizing any
threat posed by potentially pathological Abs.
METHODS
Immunization and bleeding schedules
10-week-old C57BL/6 female mice were used in the
experiments. Pretreatments (a single dose of CFA or 2.5 M
glycerol (glyc) injected subcutaneously) were performed one
week before the first administration of TTd. Non-pretreated,
CFA-pretreated or glyc-pretreated mice were immunized
with high doses of TTd (Institute of Virology, Vaccines and
Sera - Torlak, Belgrade) mixed with either glyc (TTd/glyc) or
2 % aluminum hydroxide (Al; TTd/Al) as adjuvants. Doses
of 200 μl per mouse were administered subcutaneously three
times at two-week intervals, 500 μg/ml TTd per 200 μl dose.
16 weeks after the third dose, one additional booster dose of
TTd was administered with an appropriate adjuvant. Thus
we generated six groups of dissimilarly immunized animals
(10 mice per group) from the six possible permutations of
adjuvant and pretreatment.
The TTd used for immunization had passed the tests of
specific and reverse toxicity to meet the requirements of the
European Pharmacopoeia.
 Samples of normal blood sera were collected
simultaneously from all groups by bleeding from the retro-
orbital plexus prior to any intervention, i.e. immediately
before pretreatments. Subsequent samples were similarly
taken at two-week intervals for 16 weeks followed by one
final sample taken one week after the administration of the
TTd booster dose. Each group therefore underwent 10
separate bleedings inclusive of the initial taking of normal
sera. The general methodology of our immunization and
bleeding schedules has been previously described
(Stojanovic et al., 2009; vide REFERENCES 36. infra).
The collected sera were complement depleted, aliquoted
and stored at -20 ºC until used for analyses. The sample sera
pools as assayed contained identical integrated volumes of
sera, taken at identical time points (relative to the start of
treatment) from identically immunized mice.
All animal experimentation was conducted in accordance
with our country-specific Guiding Principles for the Care and
Use of Laboratory Animals; these guidelines conform with the
provisions of the Declaration of Helsinki (as revised and
clarified); our experimentation received the approval of the
Animal Institutional Care and Use Committee at the Institute
of Immunology and Virology - Torlak.
Indirect ELISA for the detection of specific sera IgG populations
Detection of sera Abs specific for TTd, β2GPI, phospholipids
or laminin was performed by indirect enzyme-linked
immunosorbent assay (ELISA). Optimal sera dilutions were
defined according to the results of preliminary experiments
where randomly selected sera were analyzed at various
dilutions. The sera Abs’ reactivity towards specific antigens
(Ags) was simultaneously analyzed in all discrete samples.
Ag-specific sera IgG binding was detected by biotin-
labeled anti-mouse IgG (Sigma-Aldrich, St. Louis, Missouri,
USA) or by using commercially available biotin-labeled Abs
specific for murine IgG subclasses: anti-mouse IgG1, anti-
mouse IgG2b, and anti-mouse IgG3 (ICN Biomedicals Inc.,
Aurora, Ohio, USA); anti-mouse IgG2c (Jackson
ImmunoResearch Laboratories, West Grove, Pennsylvania,
USA). The commercially available Abs were used in
accordance with the manufacturers’ instructions and
incubated at room temperature (1 h). In all cases the
ExtrAvidin™-peroxidase/o-phenylenediamine (OPD) system
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany) was
used to visualize Ag-Ab interactions. Absorbance was
monitored at 492 nm and 620 nm (A492/620). The cut-off value
for each system was defined according to the A492/620 reading
in negative control wells containing samples 1 % w/v BSA in
phosphate-buffered saline (PBS) + 3 × SD. Sera samples were
considered positive when the A492/620 value exceeded the cut-
off value.
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Detection of IgG specific for TTd and β2GPI
The TTd used in ELISA had been produced at the Institute of
Virology, Vaccines and Sera - Torlak, Belgrade. β2GPI was
isolated from human plasma by a combination of precipitation
techniques and ion-exchange chromatography (Stojanovic et
al., 2009). Commercially available mouse anti-human β2GPI
IgG1, clone 5F7, (ICN Biomedicals Inc., Aurora, Ohio, USA)
was used for the identification of protein isolates.
Nunc MaxiSorp™ ELISA plates (Nunc, Roskilde,
Denmark) were covered (50 μl/well) with TTd (1 μg/ml TTd
in PBS) or β2GPI (10 μg/ml β2GPI in PBS) by overnight
adsorption (4 ºC). 1 % w/v BSA in PBS was used for blocking
at room temperature (2 h). Blocking and all subsequent steps
in the ELISA were followed by washing with 0.05 % (v/v)
Tween 20 in PBS (four times, 200 μl/well). Appropriately
diluted (1:800 in 1 % w/v BSA in PBS) sera samples were
incubated at room temperature (1h, 50 μl/well).
Detection of IgG specific for mouse laminin
Mouse laminin (Sigma-Aldrich, St. Louis, Missouri, USA) (10
μg/ml, 50 μl/well) was adsorbed onto Nunc MaxiSorp™
microtiter plates (4 h, 37 ºC). The plates were then washed
(three times, 200 μl/well PBS) and blocked with 1 % w/v
BSA in PBS. Diluted (1:400 in 1 % w/v BSA in PBS, 0.05 % v/
v Tween 20 in PBS) sera samples were added to the plates
after washing four times (200 μl/well, 0.05 % v/v Tween 20
in PBS) and then incubated overnight at 4 ºC.
Detection of IgG specific for phospholipids or gangliosides
For these ELISAs commercially available phospholipids and
gangliosides (Sigma-Aldrich Chemie GmbH, Steinheim) were
used as antigens. The reactivities of sera IgG to the following
phospholipids were analyzed: phosphatidylcholine (PtC),
phosphatidylserine (PS), phosphatidylethanolamine (PE),
phosphatidylinositol (PI), phosphatidylglycerol (PG) and
cardiolipin (CL). Disialoganglioside GD1b and
trisialoganglioside GT1b were used as antigens for the
evaluation of specific anti-ganglioside sera IgG levels.
Phospholipids (10 μg/ml in absolute ethanol, 50 μl/well)
or gangliosides (10 μg/ml in methanol, 50 μl/well) were
immobilized onto Nunc PolySorp™ ELISA plates by
evaporation at room temperature. After washing unbound
Ags (three times, 200 μl/well PBS) and blocking of free sites
(200 μl 1 % w/v BSA in PBS; 1 h, 37 ºC), the diluted (1:400 in 1
% w/v BSA in PBS, 50 ml/well) mice sera were added. To
detect anti-phospholipid IgG the sera samples were incubated
at room temperature (1 h); to detect anti-ganglioside IgG the
sera samples were incubated overnight (4 ºC). All subsequent
ELISA steps were followed by washing with 0.05 % v/v
Tween 20 in PBS (four times, 200 μl/well).
Competitive ELISA for the detection of Y7 natural Id concentration
changes in the sera of immunized mice
Two MoAbs were used to measure Y7 expression on sera
Abs: biotin-labeled F(ab)2 of the anti-idiotypic murine MoAb
Y7 (F(ab)2 Y7-B) and Y7+ human MoAb IgM DJ. The Y7
concentration was estimated from the inhibition of F(ab)2 Y7-
B binding to IgM adsorbed onto plastic. IgM DJ was bound
to a Nunc Maxisorp™ microtiter plate (50 μl/well) at a
concentration of 500 ng/ml. F(ab)2 Y7-B (200 ng/ml) was
mixed with mouse sera diluted in 1 % w/v BSA in PBS to a
final dilution of 1:100, preincubated (1 h, 25 ºC) in a water
bath and further incubated with coated IgM DJ.
ExtrAvidin™-peroxidase/OPD was used as a detector.
Percentage inhibition (PI) was calculated after the
determination of free F(ab)2 Y7-B using the standard curve of
binding to IgM DJ.
RESULTS
TTd-specific (Ab1) and anti-ganglioside (Ab2) IgG antibodies
Time-dependent fluctuations in anti-TTd and anti-
ganglioside sera IgG levels in TTd/Al and TTd/glyc-
immunized C57BL/6 mice are shown (Fig. 1 and Fig. 2). No
matter which protocol was followed, it was found that TTd
hyperimmunizations induced an intensive production of
anti-TTd specific IgG. A challenge test with tetanus toxin
confirmed that a protective immune response had developed
in all groups (data not shown). In the context of Id
networking, these TTd-specific Abs may be regarded as type
Ab1. In all groups, a dramatic rise in sera anti-TTd IgG levels
was observed during the main immunization phase, peaking
at week six (two weeks after the administration of the third
dose) and declining thereafter. Our results show that any
difference in the binding characteristics and dynamics of
these immunogen-specific sera IgG Abs was primarily a
function of the adjuvant. The highest levels of immunogen-
specific IgG were produced following TTd immunization in
the presence of adjuvant Al; levels were lower in an
identically pretreated group immunized in the presence of
adjuvant glyc. In the immediate post-immunization phase
(prior to booster administration), anti-TTd IgG levels were
found to decline with varying degrees of rapidity in mice
immunized with TTd/glyc; in TTd/Al immunized mice, sera
levels of TTd-specific IgG remained stable.
Following the booster TTd dose, however, a marked rise
in the production of anti-TTd IgG was observed only in those
immunizations administered in the presence of adjuvant
glyc; anti-TTd IgG levels following immunizations given in
the presence of adjuvant Al had already reached their
plateaux and remained stable at those levels even after the
final TTd booster dose.
In each group the increase in anti-TTd IgG sera levels
was followed by an increase in anti-ganglioside IgG
production. GD1b and GT1b are receptors for the tetanus toxin;
from this it follows that the Ag binding site of anti-
ganglioside IgG must be an internal image of the anti-TTd
Ab reactive to the ganglioside binding site found on the
tetanus Ag. In the context of idiotypic networks, anti-
ganglioside Abs may be regarded as type Ab2. A comparison
of time-dependent fluctuations in the levels of anti-TTd IgG
and anti-ganglioside IgG confirmed that in all groups the
appreciable rise in anti-TTd IgG production preceded the
appreciable rise in anti-ganglioside IgG production.
However, the most pronounced rises in anti-ganglioside Ab
levels were seen during the post-immunization period
(regardless of the immunization protocol followed), differing
in this respect from the observed patterns of increase in TTd-
specific IgG levels.
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Figure 1: Time-dependant fluctuations in anti-TTd, anti-GD1b and
anti-GT1b IgG levels within sera of non-pretreated (A), CFA-
pretreated (B) or glyc-pretreated (C) C57BL/6 mice and
hyperimmunized by TTd/Al .  L ight grey arrows indicate
pretreatments and black arrows indicate TTd injections. Each
sample (defined sera pool) was assayed in triplicate and
calculated mean A492/620 ± SE are presented.
Figure 2: Time-dependant fluctuations in anti-TTd, anti-GD1b and
anti-GT1b IgG levels within in sera of non-pretreated (A), CFA-
pretreated (B) or glyc-pretreated (C) C57BL/6 mice and then
hyperimmunized by TTd/glyc. Light grey arrows indicate pre-
treatments and black arrows indicate TTd injections. Each
sample (defined sera pool) was assayed in triplicate and
calculated mean A492/620 ± SE are presented.
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The levels of anti-ganglioside Abs were for the most part
found to be higher among pretreated (be it with CFA or glyc)
TTd-immunized C57BL/6 mice than among their non-
pretreated TTd-immunized counterparts. Likewise, anti-
ganglioside IgG production in response to the booster TTd
dose was more intensive among pretreated mice.
Analyses of specific IgG subclass contributions to the
entirety of the anti-ganglioside IgG pools showed that, for all
experimental groups, a significant moiety of these
contributing Abs belonged to subclasses IgG1 and IgG2c. The
immunizations had no significant influence on either the
dynamics or the contribution levels of any one specific anti-
ganglioside IgG subclass; the analyses (Fig. 3) of the
subclasses within anti-GD1b and anti-GT1b sera IgG pools (here
shown as found in CFA-pretreated and TTd/glyc immunized
mice only) are representative of all other mouse groups.
Anti-phospholipid, anti-β2GPI and anti-laminin IgG antibodies
The reactivity of TTd-hyperimmunized sera IgG to the
autoantigens normally recognized by NAAbs
(phospholipids, β2GPI) was analyzed; sera reactivity to
autoantigens bearing a partial structural similarity to the
tetanus toxin/toxoid was analyzed by laminin or β2GPI.
Fluctuations in the levels of anti-β2GPI, anti-
phospholipids and anti-laminin IgG AAbs following specific
immunizations were plotted against time (Fig. 4A and 4B;
Fig. 5A and 5B; Fig. 6A and 6B).
Time-dependent changes in the reactivity of sera IgG to
individual phospholipids were near identical, whatever the
phospholipid type. In the context of NAAbs, anti-PtC is
protective against infection and anti-PS IgG is active in the
removal of apoptotic cells; because of these functions, they
are the best explored of the phospholipids and so we have
chosen PtC and PS to stand for phospholipids as a whole.
We have shown that TTd-hyperimmunization initiates
production of significantly elevated levels of both anti-β2GPI
IgG and phospholipid-specific IgG. Regardless of group,
maximal sera levels of these AAbs were detected during the
post-immunization period; however, the dynamics of
production and the levels attained within individual groups
were a function of the pretreatments administered. In
pretreated mice, irrespective of adjuvant, anti-β2GPI and
anti-phospholipid IgG reached maximal sera levels between
the eight and tenth weeks following the course’s
commencement (Fig. 4A and 4B; Fig. 5A and 5B); in non-
pretreated mice these concentrations rose gradually over a
period of eight weeks during the post-immunization follow-
up (Fig.  6A and 6B).  The maximal attained sera
concentrations of anti-β2GPI and anti-phospholipid IgG
(evaluated from A492/620) were not adjuvant-dependent,
ranking (highest to lowest):  CFA-pretreated > glyc-
pretreated > non-pretreated. The shapes of curves depicting
time-dependent fluctuations in the level of defined IgG
AAbs (anti-β2GPI and anti-phospholipid) were broadly
similar for all the experimental groups (A and B on Fig. 4,
Fig. 5 and Fig. 6).
No significant time-dependent fluctuations in anti-
laminin IgG pools were seen in any of the experimental
groups (A and B on Fig. 4, Fig. 5 and Fig. 6).
The binding of Y7 F(ab)2 fragments to IgM DJ in the presence of TTd-
hyperimmunized mice sera
The probable influence of the previously described
immunization procedures on Id/anti-Id interactions and on
network perturbation was gauged from the extent to which
the binding of anti-Id MoAb Y7 F(ab)2 to its corresponding
Id (Y7+ IgM DJ) was inhibited in the sera of the TTd-
immunized C57BL/6 mice.
Levels of NAAbs vary, as one might expect given the
broad physiological spectra across which they manifest (PI of
normal sera pools was 32-50%); over any extended period of
time these levels can be expected to oscillate by as much as
20 %, thus only fluctuations exceeding this 20 % bound were
deemed significant. All immunization protocols induced
Figure 3: Influence of CFA-pretreatment and subsequent hyperimmunization by TTd/glyc on IgG subclasses levels within sera IgG
pools specific for GD1b (A) and GT1b (B). Each sample (defined sera pool) was assayed in triplicate and calculated mean A492/620 ± SE
are presented.
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Figure 4: Time-dependent fluctuations in anti-B2GPI, anti-
laminin, anti-PS and anti-PtC IgG levels within sera of of glyc-
pretreated C57BL/6 mice and hyperimmunized by TTd/Al (A) or
by TTd/glyc (B). Each sample (defined sera pool) was assayed in
triplicate and mean A492/620 ± SE are shown. Chart C plots
inhibition of F(ab)2 Y7 binding to IgM DJ (Y7+ IgM) as measured
in sera pools col lected at  def ined t ime-points f rom
glycpretreated C57BL/6 mice immunized by TTd/Al or TTd/glyc.
Each sample sera pool was assayed in triplicate and calculated
mean PI ± SE are presented. Light grey arrows indicate pre-
treatment and black arrows indicate TTd injections.
Figure 5: Time-dependent fluctuations in anti-B2GPI, anti-
laminin, anti PS and anti-PtC IgG levels within sera of of CFA-
pretreated C57BL/6 mice and hyperimmunized by TTd/Al (A) or
by TTd/glyc (B). Each sample (defined sera pool) was assayed in
triplicate and mean A492/620 ± SE are shown. Chart C plots
inhibition of F(ab)2 Y7 binding to IgM DJ (Y7+ IgM) as measured
in sera pools collected at defined time-points from CFA
pretreated C57BL/6 mice immunized by TTd/Al or TTd/glyc.
Each sample sera pool was assayed in triplicate and calculated
mean PI ± SE are presented. Light grey arrows indicate
pretreatment and black arrows indicate TTd injections.
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intensive fluctuations within NAAb pools conformant with
the inhibition of MoAb Y7 F(ab)2 - IgM DJ binding (Fig. 4C,
Fig. 5C and Fig. 6C). Whichever immunization protocol was
followed, sera collected during the post-immunization
period were more potent inhibitors of MoAb Y7 F(ab)2 - IgM
DJ interactions than were any of the normal C57BL/6 sera
collected prior to intervention. The potential of sera Abs to
inhibit MoAb Y7 F(ab)2 - IgM DJ interactions was found to be
time-dependent; a close analysis of the changes in this
inhibitory potential revealed that network perturbations
were more intensive and occurred more rapidly amongst
pretreated mice than amongst non-pretreated mice. The
adjuvant used not being a criterion, sera found to have the
greatest inhibitory effect on MoAb Y7 F(ab)2 - IgM DJ
interactions (and the degree of effect did have to be
significantly in excess of that produced by normal sera) were
collected: in the case of CFA-pretreated mice after the first
TTd dose; from glyc-pretreated mice after the second dose;
from non-pretreated mice only at the very end of the
immunization protocol.
For each group, the sera’s marked inhibitory potential
persisted until the ninth week post-immunization; its
inhibitory potential  then fell  abruptly and was not
significantly restored by the final TTd-booster dose
administration.
DISCUSSION
In this paper we show that, in C57BL/6 mice, TTd
hyperimmunization (whichever of our chosen protocols
governed the immunizations) induces a high level of
immunogen specific IgG production. There was a concomitant
rise in the reactivity of sera IgG towards various autoantigens
(AAgs), accompanied by quantitative disturbances in
preexisting Id/anti-Id interactions demonstrated by the
inhibition of MoAb Y7 and Y7+ IgM DJ binding.
Our results show that the TTd-specific and the
autoreactive immune responses (which developed in
tandem) are differently regulated: the immunogen-specific
immune response was primarily shaped by the adjuvant
used (whether Al or glyc); the dynamics and the intensities
of the self-directed immune responses were linked to the
pretreatments administered.
TTd-hyperimmunization in all  groups induced a
significant rise in reactivity towards the AAgs commonly
recognized by NAAbs, as gangliosides,  β2GPI and
phospholipids. The reactivity of sera IgG towards mouse
laminin (rarely recognized by mouse NAAbs) did not alter
significantly within any experimental group, a result which,
whilst implying that murine laminin tolerance is strictly
regulated, is unsurprising given that anti-laminin IgGs are
overtly pathogenic in the murine system. This invariance in
reactivity accords with recent data showing that the
robustness of any tolerance mechanism is AAg-specific and
correlates inversely with the contributions of specific AAbs
to the pool of NAAbs (Wang et al., 2003).
That autoimmunity is associated with the triggering of
increases in AAb production and disturbances in Id
networks is known; the trigger itself is not. Whether the
initiating process is driven by antigens, by polyclonal B cell
activation, or by both of these acting in concert, is as yet
unelucidated but either or both are plausible candidates.
Figure 6: Time-dependent fluctuations in anti-B2GPI, anti-
laminin, anti-PS and anti-PtC IgG levels within sera of non-
pretreated C57BL/6 mice and hyperimmunized by TTd/Al (A) or
by TTd/glyc (B). Each sample (defined sera pool) was assayed in
triplicate and mean A492/620 ± SE are shown. Chart C plots
inhibition of F(ab)2 Y7 binding to IgM DJ (Y7+ IgM) as
measured in sera pools collected at defined time-points from
non-pretreated C57BL/6 mice immunized by TTd/Al or TTd/glyc.
Each sample sera pool was assayed in triplicate and calculated
mean PI ± SE are presented. Black arrows indicate TTd
injections.
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Our pretreatments (CFA, glyc) and adjuvants (Al, glyc)
are all potent polyclonal stimulators. Aluminum may be
known, first and foremost, as a B cell stimulator but it also
influences Ag-presenting cell activity (Brewer, 2006).
Glycerol, as a chemical chaperone, is a polyclonal T cell
activator (Ghumman et al., 1998). CFA (a mix of TLR
agonists) acts on TLRs as expressed in C57BL/6 mice
resulting in both B and T cell activation.
The detected secretion of both Th1 (INF-γ, TNF-α, IL-12)
and Th2 cytokines (IL-4 and IL-5) may be consequential to
the influence of CFA upon T cells (Billiau & Matthys 2001).
CFA recruits natural memory cells (MZ B and B1) to assist in
the interrogation of B cells (Bernasconi et al., 2002, Ha et al.,
2006). This in turn leads to the generation of an Ag-specific
adaptive immune response based on archetypes contained in
and drawn from the pool of all anti-bacterial memories; thus
there would appear to be latent or innate blueprints which
can be used to produce an interim specific Ab response, a
stopgap to afford the breathing-space necessary to permit a
conventional adaptive response to develop. The importance
of TLR activation in the production of AAbs is implicit in the
fact that it was the CFA-pretreated mice that produced AAbs
more quickly and in greater quantities than did any other
experimental group.
Ags may also be drivers of anti-β2GPI and anti-
ganglioside Ab production. TTd may incite anti-β2GPI Ab
production by molecular mimicry: TTd and β2GPI share
partial similarities of three-dimensional structure (Inic-
Kanada et al., 2009). An alternative hypothesis is that anti-
ganglioside Abs are generated in the context of Id/anti-Id
networking; mice immunized (varying strategies) with
gangliosides subsequently displayed poor antibody
responses (Bowes et al., 2002). As the gangliosides GD1b and
GT1b are tetanus toxin receptors, an antigen-binding site
found on an anti-ganglioside IgG might be an internal image
of an anti-TTd Ab, reactive towards the ganglioside-binding
site found on the tetanus antigen. In an idiotypic network,
anti-TTd IgG might be typed as Ab1 with anti-ganglioside
Abs typed as Ab2. This hypothesis is not in conflict with the
sequence of events observed during specific Ab secretion: an
appreciable rise in anti-TTd IgG sera concentration precedes
the secretion of anti-ganglioside IgG. The increase in IgG2c
ganglioside-specific antibodies after the TTd booster dose
carries with it  the implication that both Id/anti-Id
interactions and Th1 cytokines are together involved in the
synthesis of these former.
If  maintenance of tolerance to self-structures is
paramount in the immune system hierarchy then protection
against those microbial invaders which impersonate (to a
greater or lesser extent) host self-structures is problematic;
how to mount a defense against the invader without
compromising this tolerance and inducing an autoimmune
pathology? It seems inevitable that, in any rapid defense
mounted, a tipping-point will be reached when polyclonal
activation normally preventive (in a heuristically
homeostatic system) of autoimmunity will itself initiate a
runaway autoimmune response.
If polyclonal B cell activation alone (or changes in
quantitative interactions in the public Id) acts as the trigger
for autoimmunity then the regulatory potential of the NAAb
network is nullified; the constitutive recurrence (dynamic
and metadynamic properties of interactions) of the public Id
would be neglected and thus the full regulatory potential of
NAAbs could never be exploited. Thus polyclonal B cell
activation cannot be the sole culprit; somatic mutation and
affinity maturation are prerequisites aided implicitly by
regulator-T cells, helper-T and follicular B cells; a variety of
antigens and strong autoantibodies are complicit.
It follows then that any ability to neutralize the threats
posed by the multiplicity of near self-similar invasive bodies
must be integral to a system in its entirety (reliant upon
mutations in the public Id which whilst connected retains it
utility) thus explaining the observed differences in the
responses of BALB/c and C57BL/6 mice to TTd
hyperimmunization.
Any heightened NAAb connectivity recruits autoreactive
B cells to the network; these themselves then become subject
to the dynamics of the network, both limiting their clonal
reproductivity and inhibiting Ab secretion. These dynamics
also shepherd NAAb complements into the network fold.
The sequence then becomes recursively self-iterating,
gathering in all  functionally autoreactive B cells
subsequently produced.
It is worth noting that, within newly produced or
immunization-produced AAb pools, perturbances and
synchronous fluctuations in AAb levels were induced; we
were either witnessing a cross-reactivity with NAAbs or the
AAbs were themselves members of a NAAb network. We
saw that a quantitative disturbance in preexisting Id/anti-Id
interactions was induced by TTd hyperimmunization and
that this was most noticeable in groups pretreated with CFA
or glyc.
As stated, if polyclonal B cell activation is the primary
factor in the initiation and continued induction of
autoimmunity in BALB/c mice, then the ability of C57BL/6
mice to sidestep the threats arising from TTd
hyperimmunization must be genetically integral to their
immune system. Let us now attempt to explore this issue
further.
The question: why does an identical immunization
protocol induce a characteristic pathology (APS with fetal
resorption) in BALB/c mice yet not do so in C57BL/6 mice?
Consider first the numerous VH functional genes, differently
expressed in different mouse strains. The relative map
positions of the VH gene families in Igha and Ighb
haplotypes are indistinguishable (Brodeur et al., 1988) and it
is thus unlikely that the differential expression of VH families
in BALB/c and C57BL/6 mice is due to differences in VH
gene organization. But it is documented that, in the C57BL/6
strain, anti-PtC Abs are mainly encoded by VH1
immunoglobulin heavy-chain variable region gene families;
usage of the VH2 gene predominates in BALB/c mice. In the
anti-PtC Ab, heavy-chains encoded by the VH1 and VH2
genes are combined with the Vκ9 and Vκ4 light-chain genes
respectively; JH1 genes combine with third complementary
determining regions (CDR3s) of longitudinal homogeneity
(Poncet et al., 1990, Carmack et al., 1990). Diversity within
the anti-PtC Ab pools encoded by VH1 is assured by the high
number of genes within that family, greatly increasing the
likelihood that a broad spectrum of germ-line encoded end
products will be generated (Seidl et al., 1999).
AAbs encoded by the significantly smaller VH2 family
(VHQ52 gene family) display a greater diversity (N-region
additions and variable length CDR3s) and so may easily slip
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through the regulatory net of natural Id/anti-Id interactions
(Seidl et al., 1999). That synchronous fluctuations within
newly produced or immunization-produced AAb pools were
seen in C57BL/6 mice (with Id/anti-Id disturbance most
noticeable in pretreated animals) suggests that it is intense
polyclonal stimulation in a milieu of Id/anti-Id interactions
that keeps the system in an organized state, with any
detectable pathologies eliminated either through hysteresis
or the total suppression of an autoimmune response.
Self-tolerance is the sine qua non of the immune system
as we understand it. Each new immune response is deemed
to be generated from and within a network of preexisting
NAAb idiotypes. It follows that a tetanus toxoid-specific
immune response will be generated within the interstices of
Id/anti-Id interactions framing phospholipid-specific
NAAbs. Abs to Ags such as PtC must exist innately, a priori
to any Ag first encounter; it is hard if not impossible to posit
that somatic mutation and selection alone can create and
account for specificities to Ags yet to be encountered. It
follows that an imperfect or inchoate NAAb network,
consequential to a genetically predetermined deficiency in
the library of NAAb producing cells, may leave BALB/c
mice vulnerable to APS (Avrameas et al., 2007). The more
diverse palette of AAbs found in C57BL/6 mice has painted
a network capable of preventing APS.
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